Price alert —
Sign in to get a one-time email the moment ENOV crosses your price. Free accounts included.
Sign in / create a free accountEnovis Corporation is a healthcare company listed in the US.
ENOV last traded at $27.07, down 3.6% on the day; that's in the upper part of its 52-week range ($19.14–$28.69). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 60), the trend is quiet (ADX 17), and trading is light at 0.7× normal volume. On the business side, revenue is growing 5% year over year and the business keeps about 9 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $40.67 (fair range $41–$117); today's price leaves a +37% cushion below that estimate. The model's verdict is “Deep value” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Current ratio 2.02 (antifragile)
- ✓ Gross margin 61% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.80 (fragile)
- ⚠ Negative retained earnings
Price implies ~1% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
ENOV is a $1.5 billion company.